Better and safer cancer therapeutics first in line
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Meet LiPlasome Pharma at the CRS 2009 Exposition
LiPlasome Pharma is represented at conventions and other scientific events around the world...
Please note - new office address from March 30th, 2009
Liplasome Pharma is moving into new office and research facilities ...
Annual Report 2007
View or download Annual Report 2007, and learn more about LiPlasome Pharma, the lipid technology and...
Creating a successful business with a new visual identity
The upcoming biotech company LiPlasome Pharma A/S is launching a new visual identity...



